A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment

By                    

Oncology Reports, Vol. 33, Iss. 4, 2015-01 ,pp. : 1585-1592

Spandidos Publications

Access to resources Recommend Favorite

Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer

By Salminen Eeva   Ala-Houhala M   Korpela J   Varpula M   Tiitinen S. L.   Halleen J. M.   Väänänen H. K  

Acta Oncologica, Vol. 44, Iss. 7, 2005-10 ,pp. : 742-747

Informa Healthcare

Access to resources Recommend Favorite

Soluble CD44 Molecules in Serum of Patients with Prostate Cancer and Benign Prostatic Hyperplasia

By Jung K.   Lein M.   Weiss S.   Schnorr D.   Henke W.   Loening S.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 627-630

Elsevier

Access to resources Recommend Favorite

Levels of Circulating Intercellular Adhesion Molecule-1 in Patients with Metastatic Cancer of the Prostate and Benign Prostatic Hyperplasia

By Wolff J.M.   Stephenson R.N.   Chisholm G.D.   Habib F.K.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 339-341

Elsevier

Access to resources Recommend Favorite

Are We Overlooking Stage a Prostate Cancer in Patients Treated for Benign Prostatic Hyperplasia with Medical or Minimally Invasive Modalities?

By Kocurek J.N.   Orihuela E.   Neal D.E.   Pow-Sang M.   Warren M.M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 4, 1995-07 ,pp. : 153-155

Elsevier

Access to resources Recommend Favorite